| Name | Title | Contact Details |
|---|
Geneos is developing personalized immunotherapies against tumor specific neoantigens which arise from gene mutations in cancerous cells.
Same taste, but plant-based. A food revolution has started. Know the future of food. Why not?
Celladon is a privately held biotechnology company founded with the goal of developing molecular therapies for cardiovascular diseases. Breakthroughs in the basic understanding of the cardiovascular networks combined with powerful new technologies have provided the foundation for new, rational, and technologically sophisticated approaches to cardiovascular treatments. Our first product candidate is designed to target the key enzyme deficiency in advanced heart failure which regulates calcium cycling and contractility in heart muscle cells.
Solugen is a venture-backed biotech startup that replaces petroleum based products with plant-derived substitutes.
Relay has developed a proprietary software solution for stakeholders of the biopharmaceutical technology licensing and development process.